OrisDX Wins $665K in UChicago’s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers
OrisDX Wins $665K in UChicago’s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers
CHICAGO–(BUSINESS WIRE)– #accelerator–UChicago’s 2022 New Venture Challenge invests record $1.76M in student startups, awards first-place to OrisDX for saliva test to diagnose oral cancers